Management of Septic Cardiomyopathy with Refractory Hypotension

Initial Fluid Resuscitation

Administer an initial crystalloid bolus of at least 30 mL/kg within the first three hours of shock, even in patients with pre‑existing heart failure or reduced ejection fraction; withholding this volume is not supported by evidence. [Intensive Care Medicine guideline] 1
Guide ongoing fluid administration with dynamic variables (e.g., pulse‑pressure variation, stroke‑volume variation) and static variables (arterial pressure, heart rate, urine output, mental status); continue fluid challenges only while measurable hemodynamic improvement is observed. [Intensive Care Medicine guideline] 1
Discontinue fluid infusion when no further hemodynamic improvement occurs or when signs of fluid overload appear (elevated jugular venous pressure, increasing respiratory rate, falling oxygen saturation, pulmonary crackles). [Intensive Care Medicine guideline] 1

Start norepinephrine at 0.05–0.1 µg/kg/min (≈5–10 µg/min for a 70‑kg adult) promptly after the initial fluid bolus if hypotension persists; do not delay vasopressor initiation while pursuing aggressive fluids. [Intensive Care Medicine guideline] 1
Target a mean arterial pressure (MAP) of ≥65 mmHg in most patients; for individuals with chronic hypertension, aim for MAP 70–85 mmHg because their autoregulatory curve is shifted rightward. [Intensive Care Medicine guideline] 1
Place an arterial catheter for continuous blood‑pressure monitoring as soon as practicable after vasopressor initiation. [Intensive Care Medicine guideline] 1

Add vasopressin at a fixed dose of 0.03 units/min when norepinephrine dose reaches 0.1–0.25 µg/kg/min and MAP remains <65 mmHg; vasopressin should never be used as monotherapy. [Intensive Care Medicine guideline] 1
Do not exceed vasopressin doses of 0.03–0.04 units/min except as salvage therapy, as higher doses cause cardiac, digital, and splanchnic ischemia without additional hemodynamic benefit. [Intensive Care Medicine guideline] 1

Introduce epinephrine starting at 0.05 µg/kg/min and titrate up to 0.3 µg/kg/min when MAP cannot be achieved with the combination of norepinephrine and vasopressin. [Intensive Care Medicine guideline] 1

Initiate dobutamine at 2.5–20 µg/kg/min when MAP is adequate (≥65 mmHg) but tissue hypoperfusion persists (elevated lactate, low urine output, altered mental status, cold extremities), especially when echocardiography shows myocardial dysfunction. [Intensive Care Medicine guideline] 1
Perform bedside transthoracic echocardiography to assess left‑ventricular ejection fraction, right‑ventricular function, and filling pressures; this distinguishes vasodilatory shock (high cardiac output, low SVR) from cardiogenic shock (low cardiac output, high SVR) and guides therapy selection. [Intensive Care Medicine guideline] 1
Dobutamine is the preferred inotrope for low‑output states with adequate left‑ventricular filling pressure because it improves cardiac output without markedly increasing myocardial oxygen demand compared with alternative agents. [Intensive Care Medicine guideline] 1

Measure serum lactate at the time of septic shock recognition and repeat within six hours if elevated; lactate normalization serves as a resuscitation endpoint. [Intensive Care Medicine guideline] 1
Target urine output of ≥0.5 mL/kg/h as a bedside indicator of sufficient renal perfusion. [Intensive Care Medicine guideline] 1
Assess capillary refill time (<2 seconds), skin temperature, peripheral pulses, and mental status as additional perfusion endpoints. [Intensive Care Medicine guideline] 1

Do not use dopamine as first‑line therapy; it is associated with an absolute 11% increase in mortality and a higher incidence of supraventricular and ventricular arrhythmias compared with norepinephrine. [Intensive Care Medicine guideline] 1 – Strength of evidence: Grade 1A (mortality)
Low‑dose dopamine for renal protection is contraindicated (Grade 1A recommendation against). [Intensive Care Medicine guideline] 1
Reserve phenylephrine for only three scenarios: (1) serious arrhythmias induced by norepinephrine, (2) documented high cardiac output with persistent hypotension, or (3) salvage therapy after failure of all other agents. [Intensive Care Medicine guideline] 1

Consider hydrocortisone 200 mg/day intravenously (e.g., 50 mg every 6 hours) for shock reversal if hypotension remains refractory to vasopressors after at least four hours of high‑dose therapy. [Intensive Care Medicine guideline] 1
Target a hemoglobin concentration of 7–9 g/dL in the absence of tissue hypoperfusion, ischemic coronary disease, or acute hemorrhage. [Intensive Care Medicine guideline] 1

Administer broad‑spectrum intravenous antibiotics within one hour of septic shock recognition; each hour of delay reduces survival by approximately 7.6 %. [Surviving Sepsis Campaign guidance] 2
Obtain at least two sets of blood cultures (aerobic and anaerobic) before starting antibiotics, but do not postpone antimicrobial therapy for more than 45 minutes to obtain cultures. [Surviving Sepsis Campaign guidance] 2

Do not withhold the initial 30 mL/kg fluid bolus in patients with known heart failure or reduced ejection fraction; delayed resuscitation increases mortality. [Intensive Care Medicine guideline] 3
Do not rely solely on MAP to guide therapy; normal MAP can coexist with severe tissue hypoperfusion (“cold shock”). Always incorporate lactate, urine output, mental status, and skin perfusion assessments. [Surviving Sepsis Campaign guidance] 2
Cease aggressive fluid administration when no hemodynamic improvement is observed, as fluid overload worsens outcomes and may paradoxically exacerbate shock. [Surviving Sepsis Campaign guidance] 2
Do not exceed vasopressin doses beyond 0.03–0.04 units/min; higher doses cause end‑organ ischemia without additional benefit. [Intensive Care Medicine guideline] 1